Somebody was complaining that recruitment was too slow. Now the same people will complain that DXB have forked out hefty sums to open up additional sites recruiting additional patients. Just can't win lol.
Although a CR can never be totally ruled out, an R&D rebate, 50m options heavily in the money, potential milestone payments of $350m from Advanz and Taiba plus any upfront payment from either a China or USA deal significantly reduces the chance of this happening.
Ann: Quarterly Appendix 4C and Activities Report, page-22
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
0.010(2.30%) |
Mkt cap ! $250.5M | |||
| Open | High | Low | Value | Volume |
| 44.5¢ | 46.0¢ | 44.0¢ | $882.2K | 1.961M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 55281 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 27933 | 2 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| DXB (ASX) Chart |